Translating VOC research
into clinical applications
We are a healthtech company transforming the huge potential of VOCs biomarkers into clinical applications for early cancer detection and precision medicine.
We are currently developing our wide multi-screening platform that covers the early detection of a broad range of cancer types, reducing cancer-associated mortality worldwide.
people die every year
from cancer
lives can be saved yearly
with early cancer detection
Our values
Every cancer has a VOC signature called scent.
A cancer scent can be detected at a very early stage, before tumor growth.
How it works
Your odorprint is a powerful tool that reflects your health status
Just like a fingerprint, every individual has a unique odorprint that varies in composition and concentration.
This unique odorprint changes when an individual develops cancer and generates a disease scent that is common in all individuals who carry the same type of cancer. As this scent can be detected at very early stages, patients who carry it can benefit from efficacious and less harmful treatments, with an improved quality of life.
Your odorprint is a powerful tool that reflects your health status
Volatile organic compounds VOCs are olfactory biomarkers emitted by the body through breath, sweat, urine, feces, and vaginal secretions. They are by-products of the metabolic processes within the body and form the “odorprint” of an individual.
Just like a fingerprint, every individual has a unique odorprint that varies in composition and concentration.
This unique odorprint changes when an individual develops cancer and generates a disease scent that is common in all individuals who carry the same type of cancer. As this scent can be detected at very early stages, patients who carry it can benefit from efficacious and less harmful treatments, with an improved quality of life.
Your odorprint is a powerful tool that reflects your health status
Volatile organic compounds VOCs are olfactory biomarkers emitted by the body through breath, sweat, urine, feces, and vaginal secretions. They are by-products of the metabolic processes within the body and form the “odorprint” of an individual.
Just like a fingerprint, every individual has a unique odorprint that varies in composition and concentration.
This unique odorprint changes when an individual develops cancer and generates a disease scent that is common in all individuals who carry the same type of cancer.
As this scent can be detected at very early stages, patients who carry it can benefit from efficacious and less harmful treatments, with an improved quality of life.
Team
Founders
Our Service
will start soon!
Contact us
Get in touch
Vocoma AG
6340 Baar, Switzerland
Phone
Social
© Vocoma AG 2024. All rights reserved.
Send a message
© Vocoma AG 2024. All rights reserved.